Ambaw Bellete's most recent trade in Cg Oncology Inc. was a trade of 175,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cg Oncology Inc. | Ambaw Bellete | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 175,500 | 175,500 | - | - | Stock Option (Right to Buy) |